We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-9.25%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$429M
AUM Growth
+$23.1M
Cap. Flow
+$82.2M
Cap. Flow %
19.17%
Top 10 Hldgs %
64.97%
Holding
32
New
4
Increased
12
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$31.3M
2
OM icon
Outset Medical
OM
+$19.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$15.4M
4
TXG icon
10x Genomics
TXG
+$13.6M
5
DXCM icon
DexCom
DXCM
+$7.44M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.4M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$4.28M
3
AZN icon
AstraZeneca
AZN
+$4.11M
4
ARGX icon
argenx
ARGX
+$3.09M
5
KYMR icon
Kymera Therapeutics
KYMR
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYEL icon
26
Lyell Immunopharma
LYEL
$365M
$652K 0.15%
5,000
– –
OLK
27
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$608K 0.14%
40,000
– –
BCYC
28
Bicycle Therapeutics
BCYC
$288M
$394K 0.09%
+23,500
New +$496K
CCCC icon
29
C4 Therapeutics
CCCC
$476M
– –
-47,200
Closed -$1.15M
KYMR icon
30
Kymera Therapeutics
KYMR
$9.11B
– –
-37,000
Closed -$1.57M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$134B
– –
-82,144
Closed -$21.4M
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-52,000
Closed -$4.28M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q2 2022 Portfolio in Review

As of Q2 2022, Eagle Health Investments held 32 positions worth $429M, up 5.7% from $406M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Eagle Health Investments deployed $82.2M of net new capital in Q2 2022, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was Illumina: 122,443 shares worth $22M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was AstraZeneca, an estimated $4.11M trimmed.

  • Eagle Health Investments's largest Q2 2022 buy was Illumina: 122,443 shares worth $22M.
  • Eagle Health Investments added most to Outset Medical in Q2 2022, an estimated $19.8M increase.
  • Eagle Health Investments's biggest Q2 2022 reduction was AstraZeneca, cutting an estimated $4.11M.
  • Eagle Health Investments fully exited Vertex Pharmaceuticals in Q2 2022, selling an estimated $21.4M.
  • Eagle Health Investments's ten largest holdings make up 65% of its $429M portfolio in Q2 2022.
  • Eagle Health Investments opened 4 new positions and closed 4 in Q2 2022.
  • Eagle Health Investments's portfolio value rose 5.7% quarter-over-quarter to $429M.

Based on Eagle Health Investments's 13F filing for Q2 2022, filed 11 Aug 2022.